Table 1 Overview of traits included in this study.
From: Local genetic correlations exist among neurodegenerative and neuropsychiatric diseases
Trait type | Trait | Abbreviation | N | N cases | N controls | Chr | Global h2 (SE) | h2 Z-score | Original study |
|---|---|---|---|---|---|---|---|---|---|
Disease | Alzheimer’s disease Clinically diagnosed + UK Biobank proxy cases and controls | AD | 455,258 | 71,880 (46,613 proxy) | 383,378 (318,246 UK biobank) | 1-22 | 1.5% (0.2) | 7.14 | Jansen et al.26 |
Disease | Alzheimer’s disease Clinically diagnosed | AD (no proxy) | 63,926 | 21,982 | 41,944 | 1-22 | 7.1% (1.1) | 6.25 | Kunkle et al.27 |
Disease | Bipolar disorder Clinically diagnosed + UK Biobank self-report during interview with nursea | BIP | 413,466 | 41,917 (1116 self-report) | 371,549 (58,113 UK biobank) | 1-22 | 7.1% (0.3) | 26.2 | Mullins et al.28 |
Disease | Lewy body dementia Autopsy-confirmed + clinically diagnosed | LBD | 6618 | 2591 (1789 autopsy-confirmed) | 4,027 | 1-22 | 17.1% (7.6) | 2.27 | Chia et al.5 |
Disease | Major depressive disorder excluding 23andMe Clinically diagnosed (33 PGC cohorts) + UK Biobank broad depression phenotypeb | MDD | 500,199 | 170,756 (127,552 UK Biobank broad depression) | 329,443 (233,763 UK Biobank) | 1-22 | 6% (0.2) | 26 | Howard et al.29 |
Disease | Parkinson’s disease excluding 23andMe Clinically diagnosed + UK Biobank proxy cases and controls | PD | 482,730 | 33,674 (18,618 proxy) | 449,056 (436,419 UK biobank) | 1-22 | 1.9% (0.2) | 10.9 | Nalls et al.3 |
Disease | Parkinson’s disease excluding 23andMe Clinically diagnosed | PD (no proxy) | 27,693 | 15,056 | 12,637 | 1-22 | 30.6% (2.8) | 11.1 | Nalls et al.3 |
Disease | Schizophrenia Clinically diagnosed | SCZ | 105,318 | 40,675 | 64,643 | 1-22, X | 41% (1.4) | 29.7 | Pardiñas et al.30 |
Gene expression | eQTLGen Blood-derived eQTLs | eQTLGEN | 31,684 | – | – | 1-22 | – | Vosã et al.42 | |
Gene expression | PsychENCODE Brain-derived eQTLs | PSYCHENCODE | 1387 | – | – | 1-22 | – | Wang et al.43 |